This product is a kind of mucopolysaccharide hydrolase widely distributed in organisms. It can liquefy the insoluble polysaccharides in the cell walls of Gram-positive bacteria and hydrolyze them into soluble mucopeptides. It is a natural anti-infective substance with bactericidal effects. It has antibacterial, antiviral, anti-inflammatory effects, can enhance the efficacy of antibiotics and accelerate tissue recovery.

Azithromycin is a 15-membered macrolide antibiotic. In vitro tests have shown that azithromycin has antibacterial effects on a variety of common pathogens in clinical practice, including: Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria, sexually transmitted disease microorganisms, and other microorganisms. The mechanism of action is the same as that of erythromycin, mainly binding to the 50S subunit of the bacterial ribosome and inhibiting RNA-dependent protein synthesis.

It works synergistically with hydrochlorothiazide to lower blood pressure and prolong the antihypertensive effect; high doses may cause a decrease in red blood cell parameters and changes in renal hemodynamics.

It works synergistically with valsartan to lower blood pressure and prolong the antihypertensive effect; high doses may cause renal effects, such as increased urea and creatinine levels.

This drug is a hypoglycemic sulfonylurea-oral diabetes treatment drug. Gliclazide lowers blood sugar levels by stimulating pancreatic β cells to secrete insulin. For type 2 diabetes, gliclazide can restore the first-phase insulin secretion peak in response to glucose and increase the second-phase insulin secretion. It can be seen that the insulin secretion response induced or stimulated by glucose after a meal is significantly increased.

This product is a selective histamine H1 receptor antagonist. Animal experiments show that this product has no obvious anticholinergic and anti-5-hydroxytryptamine effects, and is not easy to pass through the blood-cerebrospinal fluid barrier to act on the central H1 receptor. When used clinically, the central inhibitory effect is relatively mild.